(S)-8-chloro-11,12,13,13a-tetrahydro-1-(hydroxymethy)-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one → (S)-8-chloro-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo [1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxaldehyde
反応式
[Cl:1][C:2]1[C:7]2[C:8](=[O:21])[N:9]3[CH2:20][CH2:19][CH2:18][C@H:10]3[C:11]3[N:12]([CH:13]=[N:14][C:15]=3[CH2:16][OH:17])[C:6]=2[CH:5]=[CH:4][CH:3]=1>[O-2].[Mn+4].[O-2].C(Cl)Cl>[Cl:1][C:2]1[C:7]2[C:8](=[O:21])[N:9]3[CH2:20][CH2:19][CH2:18][C@H:10]3[C:11]3[N:12]([CH:13]=[N:14][C:15]=3[CH:16]=[O:17])[C:6]=2[CH:5]=[CH:4][CH:3]=1参加物
4
反応物 1
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of 15.2 g (50 mmol) of (S)-8-chloro-11,12,13,13a-tetrahydro-1-(hydroxymethyl)-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one, 60 g of manganese (IV) oxide and 300 ml of methylene chloride is stirred at room temperature for 1.5 hours. The mixture is suction filtered over Dicalit, the residue is rinsed with methylene chloride and the filtrate is evaporated. After recrystallization from methylene chloride/ethyl acetate there is obtained (S)-8-chloro-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo [1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxaldehyde of melting point 224°-225°.
後処理
- filtrationfiltered over Dicalit
- washthe residue is rinsed with methylene chloride
- customthe filtrate is evaporated
- customAfter recrystallization from methylene chloride/ethyl acetate there
出典と根拠
- ORDレコード
- ord-5a8c09a84a7548829dda779cc935218a
- 出典データセット
- uspto-grants-1988_10
- 特許番号
- US04775671
反応ノート
読み込み中…